FNY Investment Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

FNY Investment Advisers’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,000	Closed	-$148K	–	837
2023 Q3	$148K	Buy	+8,000	New	+$90.5K	0.09%	133

FNY Investment Advisers's ICPT Position: Q4 2023 in Review

FNY Investment Advisers sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 8,000 shares — an estimated $148K sold.

FNY Investment Advisers first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $148K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

FNY Investment Advisers reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
FNY Investment Advisers sold 8,000 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $148K.
FNY Investment Advisers first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
FNY Investment Advisers's Intercept Pharmaceuticals, Inc. position peaked at $148K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on FNY Investment Advisers's 13F filing for Q4 2023, filed 12 Jan 2024.